INOVOTION is a biotech company which offers you a unique in vivo technology dedicated to oncology and immuno-oncology efficacy studies and early toxicity evaluations.
Our Fast, Sensitive, Reliable and Affordable assay will save you time and money, to give you a clear competitive advantage.
This breaking-thought technology uses an immunocompetent xenograft chicken embryo to provide an early analysis of your anti-cancer treatments before the classical preclinical stages. By eliminating low-value molecules early, INOVOTION accelerates your drug discovery process, increases your R&D productivity, and reduces its costs.
It’s a rapid Go/No-Go decision with multi-cancer screening capacities.
This next generation of in vivo efficacy and toxicity tests covers four main aspects:
EFFICACY assays for your treatments in oncology and immuno-oncology
EARLY TOXICITY assays for your drug candidates
TARGET VALIDATION in oncology
MULTI-CANCER SCREENING to (re)positioning your treatment
We help chemists and biologists from companies and universities to validate a target and develop treatments by getting them through in vivo evaluation while staying within their budget.
These accessible efficacy and toxicity assays open new perspectives of screening for a wide variety of project research.
INOVOTION has developed a new assay dedicated to the evaluation of biomaterials' behavior (angiogenesis, biocompatibility, toxicity, impact on fibrosis, and infiltration of host or immune cells…).
Our Fast, Sensitive, Reliable and Affordable assay will save you time and money, to give you a clear competitive advantage.
This breaking-thought technology uses an immunocompetent xenograft chicken embryo to provide an early analysis of your anti-cancer treatments before the classical preclinical stages. By eliminating low-value molecules early, INOVOTION accelerates your drug discovery process, increases your R&D productivity, and reduces its costs.
It’s a rapid Go/No-Go decision with multi-cancer screening capacities.
This next generation of in vivo efficacy and toxicity tests covers four main aspects:
EFFICACY assays for your treatments in oncology and immuno-oncology
EARLY TOXICITY assays for your drug candidates
TARGET VALIDATION in oncology
MULTI-CANCER SCREENING to (re)positioning your treatment
We help chemists and biologists from companies and universities to validate a target and develop treatments by getting them through in vivo evaluation while staying within their budget.
These accessible efficacy and toxicity assays open new perspectives of screening for a wide variety of project research.
INOVOTION has developed a new assay dedicated to the evaluation of biomaterials' behavior (angiogenesis, biocompatibility, toxicity, impact on fibrosis, and infiltration of host or immune cells…).
Focus Areas
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
